Стимуляция регенерации костной ткани с использованием костных морфогенетических белков: современные концепции
- Авторы: Мухаметов У.Ф.1, Люлин С.В.2, Борзунов Д.Ю.3, Гареев И.Ф.4
-
Учреждения:
- Республиканская клиническая больница им. Г.Г. Куватова
- Медицинский центр «Кармель»
- Уральский государственный медицинский университет
- Башкирский государственный медицинский университет
- Выпуск: Том 13, № 4 (2021)
- Страницы: 15-30
- Раздел: Научный обзор
- Статья получена: 06.10.2021
- Статья одобрена: 05.11.2021
- Статья опубликована: 15.12.2021
- URL: https://journals.eco-vector.com/vszgmu/article/view/82711
- DOI: https://doi.org/10.17816/mechnikov82711
- ID: 82711
Цитировать
Полный текст
![Открытый доступ](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Аннотация
Восстановление кости после перелома или другой травмы — одна из актуальных проблем современной ортопедии и травматологии. Более 20 типов костных морфогенетических белков входят в суперсемейство трансформирующего фактора роста бета. Выявлено, что такие типы, как BMP-2, -4, -6, -7 и -9, обладают наиболее выраженными остеогенными свойствами. Они вызывают миграцию, пролиферацию и дифференцировку мезенхимальных стволовых клеток с образованием остеобластов и хондробластов, а также оказывают индуктивное воздействие на различные стадии процесса заживления костной ткани, такие как ангиогенез, образование костной мозоли и ремоделирование кости. Некоторые рекомбинантные костные морфогенетические белки, например, rhBMP-2 и rhBMP-7, одобренные для клинического использования человеком Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA, США), применяют в сочетании с костными трансплантатами для активизации репаративного остеогенеза при лечении травм и замещении костных дефектов в хирургии позвоночника. Поэтому использование уникальных свойств этих белков стало одним из перспективных и быстроразвивающихся направлений практической медицины. Статья посвящена анализу наиболее важных концепций применения костных морфогенетических белков для стимуляции регенерации костной ткани.
Ключевые слова
Полный текст
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Об авторах
Урал Фаритович Мухаметов
Республиканская клиническая больница им. Г.Г. Куватова
Email: ufa.rkbkuv@doctorrb.ru
ORCID iD: 0000-0003-3694-3302
канд. мед. наук
Россия, 450008, Уфа, ул. Ленина, д. 3Сергей Владимирович Люлин
Медицинский центр «Кармель»
Email: carmel74@yandex.ru
ORCID iD: 0000-0002-2549-1059
SPIN-код: 4968-8680
Scopus Author ID: 6701421057
ResearcherId: M-8114-2013
д-р мед. наук, профессор
Россия, ЧелябинскДмитрий Юрьевич Борзунов
Уральский государственный медицинский университет
Email: borzunov@bk.ru
ORCID iD: 0000-0003-3720-5467
SPIN-код: 6858-8005
Scopus Author ID: 17433431500
д-р мед. наук, профессор
Россия, ЕкатеринбургИльгиз Фанилевич Гареев
Башкирский государственный медицинский университет
Автор, ответственный за переписку.
Email: ilgiz_gareev@mail.ru
ORCID iD: 0000-0002-4965-0835
SPIN-код: 3839-0621
Scopus Author ID: 57206481534
PhD
Россия, 450008, Уфа, ул. Ленина, д. 3Список литературы
- Колсанов А.В., Суслин С.А., Вавилов А.В. и др. Профилактика рисков временных, медицинских и экономических затрат при плановой госпитализации в многопрофильный стационар // Профилактическая медицина. 2021. Т. 24, № 7. С. 117–122. doi: 10.17116/profmed202124071117
- Ананьева А.Ш., Бараева Л.М., Быков И.М. и др. Моделирование повреждений костных структур в экспериментах на животных // Инновационная медицина Кубани. 2021. № 1. С. 47–55. doi: 10.35401/2500-0268-2021-21-1-47-55
- Zhang Y., Ma J., Zhang W. Berberine for bone regeneration: Therapeutic potential and molecular mechanisms // J. Ethnopharmacol. 2021. Vol. 277. P. 114249. doi: 10.1016/j.jep.2021.114249
- Bal Z., Kushioka J., Kodama J. et al. BMP and TGFbeta use and release in bone regeneration // Turk. J. Med. Sci. 2020. Vol. 50, No. SI–2. P. 1707–1722. doi: 10.3906/sag-2003-127
- Sampath T.K., Reddi A.H. Discovery of bone morphogenetic proteins – A historical perspective // Bone. 2020. Vol. 140. P. 115548. doi: 10.1016/j.bone.2020.115548
- Wu Z., Zhou B., Chen L. et al. Bone morphogenetic protein-2 against iliac crest bone graft for the posterolateral fusion of the lumbar spine: A meta-analysis // Int. J. Clin. Pract. 2021. Vol. 75, No. 4. P. e13911. doi: 10.1111/ijcp.13911
- Кузнецова В.С., Васильев А.В., Бухарова Т.Б. и др. Безопасность и эффективность применения морфогенетических белков кости 2 и 7 в стоматологии // Стоматология. 2019. Т. 98, № 1. С. 64–69. doi: 10.17116/stomat20199801164
- Bannwarth M., Smith J.S., Bess S. et al. Use of rhBMP-2 for adult spinal deformity surgery: patterns of usage and changes over the past decade // Neurosurg. Focus. 2021. Vol. 50, No. 6. P. E4. doi: 10.3171/2021.3.FOCUS2164
- Christian J. A tale of two receptors: Bmp heterodimers recruit two type I receptors but use the kinase activity of only one // Proc. Natl. Acad. Sci. USA. 2021. Vol. 118, No. 19. P. e2104745118. doi: 10.1073/pnas.2104745118
- Vassiliou A.G., Keskinidou C., Kotanidou A. et al. Knockdown of bone morphogenetic protein type II receptor leads to decreased aquaporin 1 expression and function in human pulmonary microvascular endothelial cells // Can. J. Physiol. Pharmacol. 2020. Vol. 98, No. 11. P. 834–839. doi: 10.1139/cjpp-2020-0185
- Sun W., Li M., Zhang Y. et al. Total flavonoids of rhizoma drynariae ameliorates bone formation and mineralization in BMP-SMAD signaling pathway induced large tibial defect rats // Biomed. Pharmacother. 2021. Vol. 138. P. 111480. doi: 10.1016/j.biopha.2021.111480
- Luo X., Chang H.M., Yi Y. et al. Bone morphogenetic protein 2 upregulates SERPINE2 expression through noncanonical SMAD2/3 and p38 MAPK signaling pathways in human granulosa-lutein cells // FASEB J. 2021. Vol. 35, No. 9. P. e21845. doi: 10.1096/fj.202100670RR
- Osses N., Gutierrez J., Lopez-Rovira T. et al. Sulfation is required for bone morphogenetic protein 2-dependent Id1 induction // Biochem. Biophys. Res. Commun. 2006. Vol. 344, No. 4. P. 1207–1215. doi: 10.1016/j.bbrc.2006.04.029
- Zhao B., Katagiri T., Toyoda H. et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2 // J. Biol. Chem. 2006. Vol. 281, No. 32. P. 23246–2353. doi: 10.1074/jbc.M511039200
- Zhou H., Qian J., Wang J. et al. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo // Biomaterials. 2009. Vol. 30, No. 9. P. 1715–1724. doi: 10.1016/j.biomaterials.2008.12.016
- Chen R., Yu J., Gong H.L. et al. An easy long-acting BMP7 release system based on biopolymer nanoparticles for inducing osteogenic differentiation of adipose mesenchymal stem cells. J. Tissue. Eng. Regen. Med. 2020. Vol. 14, No. 7. P. 964–972. doi: 10.1002/term.3070
- Todd G.M., Gao Z., Hyvönen M. et al. Secreted BMP antagonists and their role in cancer and bone metastases // Bone. 2020. Vol. 137. P. 115455. doi: 10.1016/j.bone.2020.115455
- Gao Y., Zhang M., Tian X. et al. Experimental animal study on BMP-3 expression in periodontal tissues in the process of orthodontic tooth movement // Exp. Ther. Med. 2019. Vol. 17, No. 1. P. 193–198. doi: 10.3892/etm.2018.6950
- Iyer S., Pennisi D.J., Piper M. Crim1-, a regulator of developmental organogenesis // Histol. Histopathol. 2016. Vol. 31, No. 10. P. 1049–1057. doi: 10.14670/HH-11-766
- Zhao H.J., Chang H.M., Klausen C. et al. Bone morphogenetic protein 2 induces the activation of WNT/beta-catenin signaling and human trophoblast invasion through up-regulating BAMBI // Cell. Signal. 2020. Vol. 67. P. 109489. doi: 10.1016/j.cellsig.2019.109489
- Madhu V., Kilanski A., Reghu N. et al. Expression of CD105 and CD34 receptors controls BMP-induced in vitro mineralization of mouse adipose-derived stem cells but does not predict their in vivo bone-forming potential // J. Orthop. Res. 2015. Vol. 33, No. 5. P. 625–632. doi: 10.1002/jor.22883
- Gomez-Puerto M.C., Iyengar P.V., García de Vinuesa A. et al. Bone morphogenetic protein receptor signal transduction in human disease // J. Pathol. 2019. Vol. 247, No. 1. P. 9–20. doi: 10.1002/path.5170
- El Bialy I., Jiskoot W., Reza Nejadnik M. Formulation, delivery and stability of bone morphogenetic proteins for effective bone regeneration // Pharm. Res. 2017. Vol. 34, No. 6. P. 1152–1170. doi: 10.1007/s11095-017-2147-x
- Engstrand T., Veltheim R., Arnander C. et al. A novel biodegradable delivery system for bone morphogenetic protein-2 // Plast. Reconstr. Surg. 2008. Vol. 121, No. 6. P. 1920–1928. doi: 10.1097/PRS.0b013e31817151b0
- Briquez P.S., Tsai H.M., Watkins E.A., Hubbell J.A. Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion // Sci. Adv. 2021. Vol. 7, No. 24. P. eabh4302. doi: 10.1126/sciadv.abh4302
- Yang X., Han G., Pang X., Fan M. Chitosan/collagen scaffold containing bone morphogenetic protein-7 DNA supports dental pulp stem cell differentiation in vitro and in vivo // J. Biomed. Mater. Res. A. 2020. Vol. 108, No. 12. P. 2519–2526. doi: 10.1002/jbm.a.34064
- Fischer J., Kolk A., Wolfart S. et al. Future of local bone regeneration – Protein versus gene therapy // J. Craniomaxillofac. Surg. 2011. Vol. 39, No. 1. P. 54–64. doi: 10.1016/j.jcms.2010.03.016
- Mirmohseni F., Cheng T., Oveissi F. et al. Optimized synthesis of poly(deoxyribose) isobutyrate, a viscous biomaterial for bone morphogenetic protein-2 delivery // ACS Appl. Mater. Interfaces. 2019. Vol. 11, No. 3. P. 2870–2879. doi: 10.1021/acsami.8b20126
- Carreira A.C., Lojudice F.H., Halcsik E. et al. Bone morphogenetic proteins: facts, challenges, and future perspectives // J. Dent. Res. 2014. Vol. 93, No. 4. P. 335–345. doi: 10.1177/0022034513518561
- Chen R., Yu Y., Zhang W. et al. Tuning the bioactivity of bone morphogenetic protein-2 with surface immobilization strategies // Acta Biomater. 2018. Vol. 80. P. 108–120. doi: 10.1016/j.actbio.2018.09.011
- Wang J., Zhang H., Zhu X. et al. Dynamic competitive adsorption of bone-related proteins on calcium phosphate ceramic particles with different phase composition and microstructure // J. Biomed. Mater. Res. B. Appl. Biomater. 2013. Vol. 101, No. 6. P. 1069–1077. doi: 10.1002/jbm.b.32917
- Shiels S.M., Solomon K.D., Pilia M. et al. BMP-2 tethered hydroxyapatite for bone tissue regeneration: Coating chemistry and osteoblast attachment // J. Biomed. Mater. Res. A. 2012. Vol. 100, No. 11. P. 3117–3123. doi: 10.1002/jbm.a.34241
- Cheng C.H., Lai Y.H., Chen Y.W. et al. Immobilization of bone morphogenetic protein-2 to gelatin/avidin-modified hydroxyapatite composite scaffolds for bone regeneration // J. Biomater. Appl. 2019. Vol. 33, No. 9. P. 1147–1156. doi: 10.1177/0885328218820636
- Chien C.Y., Tsai W.B. Poly(dopamine)-assisted immobilization of Arg-Gly-Asp peptides, hydroxyapatite, and bone morphogenic protein-2 on titanium to improve the osteogenesis of bone marrow stem cells // ACS Appl. Mater. Interfaces. 2013. Vol. 5, No. 15. P. 6975–6983. doi: 10.1021/am401071f
- Ko E., Yang K., Shin J., Cho S.W. Polydopamine-assisted osteoinductive peptide immobilization of polymer scaffolds for enhanced bone regeneration by human adipose-derived stem cells // Biomacromolecules. 2013. Vol. 14, No. 9. P. 3202–3213. doi: 10.1021/bm4008343
- Ruhé P.Q., Kroese-Deutman H.C., Wolke J.G. et al. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits // Biomaterials. 2004. Vol. 25, No. 11. P. 2123–2132. doi: 10.1016/j.biomaterials.2003.09.007
- Zhao J., Shen G., Liu C. et al. Enhanced healing of rat calvarial defects with sulfated chitosan-coated calcium-deficient hydroxyapatite/bone morphogenetic protein 2 scaffolds // Tissue Eng. Part A. 2012. Vol. 18, No. 1–2. P. 185–197. doi: 10.1089/ten.TEA.2011.0297
- Kim M.G., Kim C.L., Kim Y.S. et al. Selective endocytosis of recombinant human BMP through cell surface heparan sulfate proteoglycans in CHO cells: BMP-2 and BMP-7 // Sci. Rep. 2021. Vol. 11, No. 1. P. 3378. doi: 10.1038/s41598-021-82955-1
- Haubruck P., Tanner M.C., Vlachopoulos W. et al. Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions // Orthop. Traumatol. Surg. Res. 2018. Vol. 104, No. 8. P. 1241–1248. doi: 10.1016/j.otsr.2018.08.008
- Teng F., Yu D., Wei L. et al. Preclinical application of recombinant human bone morphogenetic protein 2 on bone substitutes for vertical bone augmentation: A systematic review and meta-analysis // J. Prosthet. Dent. 2019. Vol. 122, No. 4. P. 355–363. doi: 10.1016/j.prosdent.2018.09.008
- Nauth A., Schemitsch E., Norris B. et al. Critical-size bone defects: is there a consensus for diagnosis and treatment? // J. Orthop. Trauma. 2018. Vol. 32 Suppl 1. P. S7–S11. doi: 10.1097/BOT.0000000000001115
- Wikesjö U.M., Polimeni G., Qahash M. Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives // Clin. Implant. Dent. Relat. Res. 2005. Vol. 7, No. 2. P. 112–119. doi: 10.1111/j.1708-8208.2005.tb00054.x
- Long J., Li P., Du H.M. et al. Effects of bone morphogenetic protein 2 gene therapy on new bone formation during mandibular distraction osteogenesis at rapid rate in rabbits // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2011. Vol. 112, No. 1. P. 50–57. doi: 10.1016/j.tripleo.2010.09.065
- Turgeman G., Zilberman Y., Zhou S. et al. Systemically administered rhBMP-2 promotes msc activity and reverses bone and cartilage loss in osteopenic mice // J. Cell. Biochem. 2002. Vol. 86, No. 3. P. 461–474. doi: 10.1002/jcb.10231
- Crasto G.J., Kartner N., Reznik N. et al. Controlled bone formation using ultrasound-triggered release of BMP-2 from liposomes // J. Control. Release. 2016. Vol. 243. P. 99–108. doi: 10.1016/j.jconrel.2016.09.032
- Smith D.M., Afifi A.M., Cooper G.M. et al. BMP-2-based repair of large-scale calvarial defects in an experimental model: regenerative surgery in cranioplasty // J. Craniofac. Surg. 2008. Vol. 19, No. 5. P. 1315–1322. doi: 10.1097/SCS.0b013e3181843369
- Kerzner B., Martin H.L., Weiser M. et al. A Reliable and reproducible critical-sized segmental femoral defect model in rats stabilized with a custom external fixator // J. Vis. Exp. 2019. No. 145. P. 10.3791/59206. doi: 10.3791/59206
- Liu F., Wells J.W., Porter R.M. et al. Interaction between living bone particles and rhBMP-2 in large segmental defect healing in the rat femur // J. Orthop. Res. 2016. Vol. 34, No. 12. P. 2137–2145. doi: 10.1002/jor.23255
- Lee J., Decker J.F., Polimeni G. et al. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs // J. Clin. Periodontol. 2010. Vol. 37, No. 6. P. 582–590. doi: 10.1111/j.1600-051X.2010.01557.x
- Ripamonti U., van den Heever B., Sampath T.K. et al. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7) // Growth Factors. 1996. Vol. 13, No. 3–4. P. 273–289. doi: 10.3109/08977199609003228
- Vincentelli A.F., Szadkowski M., Vardon D. et al. rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) in real world spine surgery. A phase IV, National, multicentre, retrospective study collecting data from patient medical files in French spinal centres // Orthop. Traumatol. Surg. Res. 2019. Vol. 105, No. 6. P. 1157–1163. doi: 10.1016/j.otsr.2019.04.023
- Baltzer A.W., Ostapczuk M.S., Stosch D., Granrath M. The use of recombinant human bone morphogenetic protein-2 for the treatment of a delayed union following femoral neck open-wedge osteotomy // Orthop. Rev. (Pavia). 2012. Vol. 4, No. 1. P. e4. doi: 10.4081/or.2012.e4
- Julka A., Shah A.S., Miller B.S. Inflammatory response to recombinant human bone morphogenetic protein-2 use in the treatment of a proximal humeral fracture: a case report // J. Shoulder Elbow Surg. 2012. Vol. 21, No. 1. P. e12–16. doi: 10.1016/j.jse.2011.06.006
- Von Rüden C., Morgenstern M., Hierholzer C. et al. The missing effect of human recombinant Bone Morphogenetic Proteins BMP-2 and BMP-7 in surgical treatment of aseptic forearm nonunion // Injury. 2016. Vol. 47, No. 4. P. 919–924. doi: 10.1016/j.injury.2015.11.038
- Murena L., Canton G., Vulcano E. et al. Treatment of humeral shaft aseptic nonunions in elderly patients with opposite structural allograft, BMP-7, and mesenchymal stem cells // Orthopedics. 2014. Vol. 37, No. 2. P. e201–e206. doi: 10.3928/01477447-20140124-26
- Ollivier M., Gay A.M., Cerlier A. et al. Can we achieve bone healing using the diamond concept without bone grafting for recalcitrant tibial nonunions? // Injury. 2015. Vol. 46, No. 7. P. 1383–1388. doi: 10.1016/j.injury.2015.03.036
- Calori G.M., Colombo M., Bucci M. et al. Clinical effectiveness of Osigraft in long-bones nonunions // Injury. 2015. Vol. 46 Suppl 8. P. S55–S64. doi: 10.1016/S0020-1383(15)30056-5
- Durdevic D., Vlahovic T., Pehar S. et al. A novel autologous bone graft substitute comprised of rhBMP6 blood coagulum as carrier tested in a randomized and controlled Phase I trial in patients with distal radial fractures // Bone. 2020. Vol. 140. P. 115551. doi: 10.1016/j.bone.2020.115551
- Govender S., Csimma C., Genant H.K. et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients // J. Bone Joint. Surg. Am. 2002. Vol. 84, No. 12. P. 2123–2134. doi: 10.2106/00004623-200212000-00001
- Sudsakorn S., Bahadduri P., Fretland J., Lu C. 2020 FDA Drug-drug Interaction Guidance: A comparison analysis and action plan by pharmaceutical industrial scientists // Curr. Drug Metab. 2020. Vol. 21, No. 6. P. 403–426. doi: 10.2174/1389200221666200620210522
- Friedlaender G.E., Perry C.R., Cole J.D. et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions // J. Bone Joint. Surg. Am. 2001. Vol. 83-A Suppl 1, No. Pt 2. P. S151–158.
- McKee M.D., Schemitsch E.H., Waddell J.P. et al. The effect of human recombinant bone morphogenic protein (rhBMP-7) on the healing of open tibial shaft fractures: results of a multi-center, prospective, randomized clinical trial // Proceedings of the 18th Annual Meeting of the Orthopaedic Trauma Association; 2002 Oct 11-13, Toronto, ON, Canada [Электронный ресурс]. Режим доступа: www.hwbf.org/ota/am/ota02/otapa/OTA02745.htm. Дата обращения: 09.12.2009.
- Bong M.R., Capla E.L., Egol K.A. et al. Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions // Bull. Hosp. Jt. Dis. 2005. Vol. 63, No. 1–2. P. 20–23.
- Oryan A., Alidadi S., Moshiri A., Bigham-Sadegh A. Bone morphogenetic proteins: a powerful osteoinductive compound with non-negligible side effects and limitations // Biofactors. 2014. Vol. 40, No. 5. P. 459–481. doi: 10.1002/biof.1177
- Kanjilal D., Cottrell J.A. Bone morphogenetic proteins (BMP) and bone regeneration // Methods Mol. Biol. 2019. Vol. 1891. P. 235–245. doi: 10.1007/978-1-4939-8904-1_17
- Jain A., Yeramaneni S., Kebaish K.M. et al. Cost-utility analysis of rhBMP-2 use in adult spinal deformity surgery // Spine (Phila Pa 1976). 2020. Vol. 45, No. 14. P. 1009–1015. doi: 10.1097/BRS.0000000000003442
- Krishnakumar G.S., Roffi A., Reale D. et al. Clinical application of bone morphogenetic proteins for bone healing: a systematic review // Int. Orthop. 2017. Vol. 41, No. 6. P. 1073–1083. doi: 10.1007/s00264-017-3471-9
- Lochmann A., Nitzsche H., von Einem S. et al. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres // J. Control. Release. 2010. Vol. 147, No. 1. P. 92–100. doi: 10.1016/j.jconrel.2010.06.021
- Alam S., Ueki K., Nakagawa K. et al. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009. Vol. 107, No. 1. P. 22–29. doi: 10.1016/j.tripleo.2008.06.025
- Summary of safety and effectiveness data. 2002. The InFUSE™ Bone Graft/LT-CAGE™ Lumbar Tapered Fusion Device [Электронный ресурс]. Режим доступа: http://www.accessdata.fda.gov/cdrh_docs/pdf/P000058b.pdf. Дата обращения: 14.02.2010.
- Carragee E.J., Chu G., Rohatgi R. et al. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis // J. Bone Joint Surg. Am. 2013. Vol. 95, No. 17. P. 1537–1545. doi: 10.2106/jbjs.l.01483
- Kelly M.P., Savage J.W., Bentzen S.M. et al. Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis // J. Bone Joint Surg. Am. 2014. Vol. 96, No. 17. P. 1417–1422. doi: 10.2106/jbjs.m.01190
- Wang X., Huang J., Huang F. et al. Bone morphogenetic protein 9 stimulates callus formation in osteoporotic rats during fracture healing // Mol. Med. Rep. 2017. Vol. 15, No. 5. P. 2537–2545. doi: 10.3892/mmr.2017.6302
- Rittenberg B., Partridge E., Baker G. et al. Regulation of BMP-induced ectopic bone formation by Ahsg // J. Orthop. Res. 2005. Vol. 23, No. 3. P. 653–662. doi: 10.1016/j.orthres.2004.11.010
- Ueland T., Stilgren L., Bollerslev J. Bone matrix levels of dickkopf and sclerostin are positively correlated with bone mass and strength in postmenopausal osteoporosis // Int. J. Mol. Sci. 2019. Vol. 20, No. 12. P. 2896. doi: 10.3390/ijms20122896
Дополнительные файлы
![](/img/style/loading.gif)